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Using a gel retardation assay and exonuclease III footprinting, we have analyzed sequence-specific DNA-binding nuclear 
factors which interact with e distal promoter element of the rat tyrosine aminotransferase gene.A factor called LspA 1, 
binding to a sequence that resembles the consensus binding site for the transcription factor Ap-1, was shown to be present 
in adult rat-liver nuclear protein extracts but not inthe extracts from embryonic liver orspl en uclei. 
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1. INTRODUCTION 
In adult animals, the rat tyrosine aminotransfer- 
ase (TAT) gene is selectively transcribed in paren- 
chymal cells of the liver and this transcription is 
regulated. Three DNase 1-hypersensitive sites in 
isolated nuclei of TAT-expressing but not of non- 
expressing cells mark important regulatory DNA 
sequences [1,2]. Two sites occur within the pro- 
moter region (HS sites I and II, respectively [1]). 
The distal site I I I  at about 2.5 kbp upstream of the 
promoter which appears specifically upon induc- 
tion of the gene expression by hormone has been 
shown to contain two cooperating lucocorticoid 
response lements [2]. Hormone-dependent DNA- 
protein interaction was observed within site I I I  in 
hepatoma cells [3] but the proteins binding within 
HS sites I and II were not dependent on glucocor- 
ticoids [4]. 
Genomic footprinting revealed cell type-specific 
(hepatoma vs non-hepatoma cells) binding of ubi- 
quitous nuclear factors to DNA sequences in HS 
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sites I and II [4]. Six DNA sequences protected by 
proteins binding in vivo and in vitro within pro- 
moter HS site I and two sequences within HS site 
II were observed, but the corresponding nuclear 
factors have not yet been characterized. It is also 
unclear whether similar nuclear factors are present 
in normal rat-liver nuclei. 
In order to elucidate how regulatory signals 
from the glucocorticoid response lements of the 
rat TAT gene are transduced to its related pro- 
moter, we have investigated the rat-liver nuclear 
factors which bind to the promoter sequences. The 
finding that 100-300 bp of upstream promoter se- 
quence of other liver-specific genes are sufficient 
to govern the low-level tissue-specific expression 
encouraged us to begin studying sequence-specific 
DNA-protein interactions within the upstream 
promoter egion around HS site I. In a previous 
s tudy,  using gel-retardation and DNase 1 foot- 
printing assays, we have analysed the rat-liver 
nuclear factors binding to the proximal promoter 
fragment (from -2  to -210  bp relative to the 
transcription start) of the rat TAT gene [5-7] and 
have found that the same nuclear factor related to 
the CTF/NF1 nuclear protein family binds to 
elements which contain the ( -155)TGGGCCAC-  
CTTCCAAT(  - 170) and ( - 37)AGCCAAT( - 43) 
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sequences [6,7]~ This ubiquitous factor was con- 
siderably enriched in the liver nuclear extracts in 
comparison to the spleen, kidney or embryonic 
liver extracts [6]. 
Here, we present data on a protein termed 
LspA1 which binds to sequences further upstream 
of the TAT  gene (from - 210 to - 313 bp). Factor 
LspA1, assayed by gel retardation and ExoI I I -  
footpr int ing techniques, appears to be a liver- 
specific nuclear protein. 
2. MATERIALS  AND METHODS 
DNA fragment A (fig.l) that was used as a 32p-probe in g l- 
retardation and exonuclease III-footprinting assays represents 
the sequence from nucleotide - 210 to - 313 of the 5 '-flanking 
region of the rat TAT gene. It was excised with HpaI from the 
plasmid pUTATS2.7 [8] kindly provided by G. Shiitz and 
subcloned into the HincII site of the pUCI2 polylinker. To 
generate 5'-end-labelled fragment A, the plasmid (pTAT 
HpaI/12) was cleaved at the HindIII site, dephosphorylated 
with calf intestinal alkaline phosphatase, labelled with 
[7-32p]ATP using I"4 polynucleotide kinase, redigested with 
EcoRI, and the labelled fragment A purified by agarose gel elec- 
trophoresis. The nuclei from adult rat liver, spleen, and em- 
bryonic liver were prepared according t  Hewish and Burgoyne 
[9]. Isolated nuclei were extracted with 0.35 M NaCI and 
solubilized proteins were fractionated by (NH)2SO4 precipita- 
tion and DNA-cellulose chromatography essentially as in 
[10,11 ] for isolation ofthe C4 protein fraction except that NaCI 
instead of (NH4)2SO4 was used to dute proteins from the DNA- 
cellulose. The protease inhibitors PMSF and sodium 
metabisulfite were added to all buffers at final concentrations 
of 1 raM. The gel-retardation assay wa  carried out essentially 
as described byFried and Crothers [12] with an ¢quimolar mix- 
ture of poly(dA-dT) • poly(dA-dT) and poly(dA) • poly(dT) used 
as the non-specific competitor DNA. ExoIII footprinting was 
carried out as described byCordingley et al. [13]. For both gel- 
retardation and footprinting assays, identical buffers, com- 
petitor DNA and incubation conditions were used. 
3. RESULTS AND DISCUSSION 
DNA sequences within nucleosome-free 
chromat in regions are the most likely elements for 
specific interactions with trans-acting regulatory 
proteins. Fragment A (fig. 1) that covers the 5 ' -side 
of the DNase 1-hypersensitive site I of  the rat TAT  
gene was used to assay for sequence-specific DNA- 
b inding factors from rat-liver nuclei by the gel- 
retardat ion technique. Fig.1 shows the effect of 
adding nuclear proteins from adult liver (lanes 
1-5,  panels A and B), spleen (lanes 6-10,  panel A) 
or embryonic liver (lanes 6 -9 ,  panel B) on the elec- 
trophoretic behaviour of 32p-labelled DNA frag- 
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Fig. 1. Restriction map of the rat TAT gene 5'-flanking region. 
Numbers indicate the positions of the nucleotides upstream of 
the major transcriptional start site (+ 1). Bracket marks the 
location of the DNase l-hypersensitive site I (HSI) that has been 
mapped by Becker et al. [1]. The short horizontal line shows 
DNA fragment A used as a 32p-probe in this study. 
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Fig.2. Gel-retardation analysis of nuclear proteins specifically 
binding to DNA fragment A. dult rat liver nuclear proteins 
(A, lanes 2-5, -90 ng//d), or spleen nuclear proteins (A, lanes 
7-10, -90ng/~l) were incubated with 32p-end-labelled 
fragment A and various concentrations f the non-specific 
competitor DNA prior to electrophoresis. Lanes: 2,7, no 
competitor added; 3,8, 25 ng//A; 4,9, 75 ng//~l; 5,10, 150 ng//~l. 
In lanes 1,6 of A, no protein was added. On (B) labelled 
fragment A was incubated with 300 ng//A of the non-specific 
competitor DNA and 0, 35, 75, 150 and 250 ng//~l of adult rat 
liver nuclear proteins (lanes 1-5, respectively) or 40, 80, 150 
and 300 ng//~l of embryonic liver nuclear extract (lanes 6-9, 
respectively). 
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ment A. Only one distinct band of slower mobility 
(A1) was observed. Complex A1 was obtained us- 
ing either a constant concentration of the proteins 
and varying concentrations of non-specific DNA 
(lanes 2-4,  panel A) or a constant concentration of 
non-specific DNA and increasing amount of pro- 
teins (lines 2-5,  panel B). When no competitor 
DNA was added, smeared bands of non-specific 
complexes were seen (line 2, panel A). To 
demonstrate the sequence specificity of complex 
A1, increasing amounts of unlabelled fragment A 
or an HpaI-SacI restriction fragment of the rat 
TAT gene promoter were added to labelled frag- 
ment A in the presence of adult rat-liver nuclear 
extract. Addition of a 10-20-fold molar excess of 
unlabelled fragment A efficiently competed for the 
factor whereas a 50-100-fold excess of the HpaI- 
SacI fragment did not compete (not shown). 
With the spleen nuclear extract no bands similar 
to At were observed, but another unique band, 
designated A2, was detected (fig.lA, lanes 8-10). 
The properties of the spleen nuclear factor respon- 
sible for the formation of the A2-complex are cur- 
rently being investigated. Whilst spleen represents 
a terminally differentiated tissue that will never ex- 
press the TAT gene, embryonic liver tissue con- 
tains cells which are competent to switch on TAT 
gene expression. It was therefore interesting to 
determine whether factors A1 or A2 are present in
embryonic liver nuclear extract. To this end, a 
series of titration experiments were performed with 
the nuclear extract prepared from embryonic rat 
liver exactly in the same way as from adult rat liver 
and spleen. The results clearly demonstrated that 
in embryonic rat liver nuclear extracts no 
sequence-specific actor binding to the fragment A
is present at all (fig. 1B, lanes 6-9; and not shown). 
Thus, factor At appears to be a liver-specific pro- 
tein present only in adults; we have termed this 
protein LspAt (liver-specific protein A1). We 
hypothesize that LspAt may be a trans-acting 
transcriptional ctivator whereas factor A2 may act 
as a terminal repressor. 
In order to determine the nucleotide sequence of 
the binding site for LspAt, we have used ex- 
onuclease II I-footprinting technique since it is 
more sensitive in comparison with commonly used 
DNase I-footprinting. The DNA-binding nuclear 
protein fraction from adult rat liver was incubated 
with fragment A 5' -end- label led either at the 3' 
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Fig.3. Exonuclease III protection mapping of LspAl binding to 
fragment A. The probe labelled as shown in the lower part of 
the figure was incubated inthe absence (lanes 1-5)or presence 
(lanes 6-10) of adult rat liver nuclear extract (250 ng/ml) plus 
300 ng/pl of the non-specific competitor (same conditions as 
those used in fig.2B, lane 5). Exonuclease III treatments were 
as follows. Lanes: 1,6, 500U//A; 2,7, 1000U//~I; 4,9, 
9000 U//A; 5,10, 18000 U//zl. Exonuclease IlI-resistant 
fragments were electrophoresed in parallel with a Maxam- 
Gilbert sequencing ladder (lane G + A). Two minor boundaries 
and the major exonuclease III stop at -231 are indicated by
arrows beside the sequence ladder. 
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I 
ACTGTTAACA CAATTTTCAT AACCAAAAAA GACCAATAAA GTTAATCACT GTCACCCCAA 
TGACAATTGT GTTAAAAGTA TTGGTTTTTT  CTGGTTATTT CAATTAGTGA CAGTGGGGTT 
-250  -230  
CTGCCCTCCA CCATTTTCTC AAACATCTCA CCAAATGACT AGAAAGAGTT AACAGGATTC 
GACGGGAGGT GGTAAAAGAG TTTGTAGAGT GGTTTACTGA TCTTTCTCAA TTGTCCTAAG - 5'
--' -41  ' Hpal 
Fig.4. DNA sequence of fragment A showing exonuclease III-protected region. A sequence homologous tobinding sites for the Ap-I 
[16-18], PEAl [15] or GCN4 [12] nuclear factors is indicated by wavy underlining. 
HpaI site ( - 210) to map the 5' -border of protein 
binding on the non-coding strands, or at the 5' 
HpaI site ( -313)  to map the 3' border on the 
coding strand. Fig.3 shows that addition of protein 
to the fragment labelled at the 3' HpaI site results 
in predominant ermination of exonuclease II I  
digestion at positions -231 and -232  (lane 10). 
These termination sites are clearly specific for add- 
ed nuclear protein fraction since corresponding 
termination is not observed in control digestions of 
fragment A in the absence of proteins (fig.3, lanes 
1-5). As the defined boundary is situated just 
20 bp from the 3'-end of fragment A, factor 
LspAl binds within the sequence from -231 to 
-210 .  When fragment A was labelled at the 5' 
HpaI site and used for exonuclease II I- 
footprinting, one termination site was observed at 
around -216  (dashed arrow, fig.4), but the band 
could not be resolved well on the sequencing el 
because of its proximity to the 3' -end of the frag- 
ment (not shown). 
Thus, defined boundaries bracket sequences 
from approximately -215  to -231/ -232  as 
shown in fig.4. The central part of this protected 
region includes the pentameric sequence TGACT 
that is found in recognition elements' binding to a
closely related family of transcription factors 
which includes yeast GCN4 [14], mouse transcrip- 
tion enhancer factor PEA1 [15], avian sarcoma 
virus v-jun oncogene [16] and human activator 
protein 1 (Ap-1) [17]. In addition to functioning as 
a basic transcription factor, Ap-1 is an enhancer- 
binding protein that mediates induction by phor- 
bol ester tumour promoters [18]. We have no 
direct evidence that the factor LspA] is actually 
related to the Ap-1. It should be noted, however, 
that the rat TAT gene belongs to the family of 
phorbol ester-inducible genes because its expres- 
sion in the Morris hepatoma 7777 ceils could be 
4-7-fold increased by the treatment with 12-0- 
tetradecanoylphorbol 13-acetate (Adler, V.V. et 
al., unpublished). Current research is directed 
towards testing whether the DNA sequence bound 
by the factor LspA] is involved in the induction of 
the rat TAT gene by phorbol esters. 
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